Synthesis and anti-tumor evaluation of new trisulfide derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 18, 2006, Pages 4826-4829

  An, Haoyun ^a   Zhu, Jenny ^a   Wang, Xiaobo ^a   Xu, Xiao ^a  

^a ACEA Biosciences Inc   (United States)

Author keywords

Anti tumor activity; SAR; Synthesis; Trisulfide

Indexed keywords

ANTINEOPLASTIC AGENT; BIS(2,4,6 TRIMETHYLBENZYL)TRISULFIDE; BIS(4 FLUOROBENZYL)TRISULFIDE; BIS(4 METHYLBENZYL)TRISULFIDE; BIS(BENZO[B]THIOPHEN 2 YLMETHYL)TRISULFIDE; BIS(PHENYLETHYLENE)TRISULFIDE; BIS(THIOPHEN 2 YLMETHYL)TRISULFIDE; DIBENZYL TRISULFIDE; NATURAL PRODUCT; PACLITAXEL; SULFIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL KINETICS; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HEP 2 CELL; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES;

EID: 33746811355     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.06.070     Document Type: Article

References (32)

1. Nygren P. Acta Oncol. 40 (2001) 166
2. Liscovitch M., and Lavie Y. IDrugs 5 (2002) 349
3. Drukman S., and Kavallaris M. Int. J. Oncol. 21 (2002) 621
4. Livett B.G., Gayler K.R., and Khalil Z. Curr. Med. Chem. 11 (2004) 1715
5. Wojcikowski K., Johnson D.W., and Gobe G. Nephrology 9 (2004) 400
6. Topliss J.G., Clark A.M., Ernst E., Hufford C.D., Johnston G.A.R., Rimoldi J.M., and Weimann B.J. Pure Appl. Chem. 74 (2002) 1957
7. Lee K.-H. J. Biomed. Sci. 6 (1999) 236
8. Hung D.T., Jamison T.F., and Schreiber S.L. Chem. Biol. 3 (1996) 623
9. Kingston D.G. Chem. Commun. (2001) 867
10. Bacher G., Beckers T., Emig P., Klenner T., Kutscher B., and Nickel B. Pure Appl. Chem. 73 (2001) 1459
11. Jordan A., Hadfield J.A., Lawrence N.J., and McGown A.T. Med. Res. Rev. 18 (1998) 259
12. Davidson B.S., Molinski T.F., Barrows L.R., and Ireland C.M. J. Am. Chem. Soc. 113 (1991) 4709
13. Compagnone R.S., Faulkner D.J., Carte B.K., Chan G., Freyer A., Hemling M.E., Hofmann G.A., and Mattern M.R. Tetrahedron 50 (1994) 12785
14. Searle P.A., and Molinski T.F. J. Org. Chem. 59 (1994) 6600
15. Lam K.S., Veitch J.A., Golik J., Krishnan B., Klohr S.E., Volk K.J., Forenza S., and Doyle T.W. J. Am. Chem. Soc. 115 (1993) 12340
16. Lee M.D., Dunne T.S., Chang C.C., Siegel M.M., Morton G.O., Ellestad G.A., McGahren W.J., and Borders D.B. J. Am. Chem. Soc. 114 (1992) 985
17. Beutler J.A., Clark P., and Alvarado A.B. J. Nat. Prod. 57 (1994) 629
18. Solly K., Wang X.-B., Xu X., Strulovici B., and Zheng W. Assay Drug Dev. Technol. 2 (2004) 363
19. De Sousa J.R., Demuner A.J., Pinheiro J.A., Breitmaier E., and Cassels B.K. Phytochemistry 29 (1990) 3653
20. Johnson L., Williams L.A.D., and Roberst E.V. Pestic. Sci. 50 (1997) 228
21. Williams L.A.D., Gardner T.L., Fletcher C.K., Naravane A., Gibbs N., and Fleishhacher R. Phytother. Res. 11 (1997) 251
22. Rosner H., Williams L.A.D., Jung A., and Kraus W. Biochim. Biophys. Acta 1540 (2001) 166
23. Harpp D.N., and Granata A. Tetrahedron Lett. (1976) 3001
24. Harpa D.N., Ash D.K., Back T.G., Gleason J.G., Orwig B.A., Vanhorn W.F., and Snyder J.P. Tetrahedron Lett. (1970) 3551
25. Harpp D.N., Gingras M., Aida T., and Chan T.H. Synthesis (1987) 1122
26. Sinha P., Kundu A., Roy S., Prabhakar S., Vairamani M., Sankar A.R., and Kunwar A.C. Organometallics 20 (2001) 157
27. Banerji A., and Kalena G.P. Tetrahedron Lett. 21 (1980) 3003
28. 3: C, 53.48; H, 3.85; F, 12.08; S, 30.59. Found: C, 53.54; H, 3.84; F, 12.35; S, 30.73.
29. 3 for other compounds) spectra of compounds: 6: δ 3.98 (s, 4H), 7.22 (d, 4H, J = 8.4 Hz), 7.29 (d, 4H, J = 8.4 Hz); 7: δ 4.17 (s, 4H), 7.23-7.28 (m, 4H), 7.35-7.43 (m, 4H); 8: δ 3.96 (s, 4H), 7.17 (d, 4H, J = 8.3 Hz), 7.45 (d, 4H, J = 8.3 Hz); 9: δ 2.33 (s, 6H), 4.01 (s, 4H), 7.14 (d, 4H, J = 8.0 Hz), 7.21 (d, 4H, J = 8.0 Hz); 10: δ 2.39 (s, 6H), 4.05 (s, 4H), 7.08-7.20 (m, 6H), 7.23-7.29 (m, 2H); 11: δ 4.04 (s, 4H), 7.41-7.49 (m, 4H), 7.51-7.58 (m, 4H); 12: δ 1.30 (s, 18H), 4.02 (s, 4H), 7.25 (d, 4H, J = 8.3 Hz), 7.35 (d, 4H, J = 8.3 Hz); 13: δ 2.27 (s, 6H), 2.42 (s, 12 H), 4.23 (s, 4H), 6.87 (s, 4H); 14: δ 4.24 (s, 4H), 6.92-6.96 (m, 2H), 6.99-7.04 (m, 2H), 7.24-7.28 (m, 2H); 15: δ 3.74 (s, 4H), 7.01 (s, 2H), 7.34-7.45 (m, 4H), 7.75 (d, 2H, J = 7.4 Hz), 7.85 (dd, 2H, J = 7.8, 1.1 Hz); 16: δ 3.05-3.11 (m, 4H), 3.13-3.18 (m, 4H), 7.19-7.27 (m, 6H), 7.30-7.35 (m, 4H); 19: δ 7.70 (d, 4H, J = 8.4 Hz), 7.84 (dd, 4H, J = 8.4, 2.4 Hz), 8.73 (s, 2H); 20: δ 7.50-7.62 (m, 4H), 8.34 (d, 2H, J = 6.6 Hz), 8.58 (d, 4H, J = 4.4 Hz).
30. Berbesy G., and Harpp D.N. Tetrahedron Lett. 35 (1994) 5381
31. Technical Bull. No. 112, 2004, Promega.
32. Xu, X.; An, H., Zhu, J.; Wang, X. B., et al. Anticancer Res., in preparation.